| S6001 |
pomaglumetad (LY404039)
|
Pomaglumetad (LY404039) is a potent agonist of recombinant human mGlu2/mGlu3 receptors with Ki of 149 nM/92 nM, and it shows >100-fold selectivity over ionotropic glutamate receptors, glutamate transporters, and other receptors. This compound has reached Phase 3.
|
-
Synapse, December 2008, 902-908
-
Schizophrenia Bulletin, 2021, 1688–1697
-
Schizophr Bull, 2021, sbab047
|
|
| S5137 |
O-Phospho-L-serine
|
O-Phospho-L-serine (Dexfosfoserine), a molecule that mimics the phosphatidylserine head group and partially blocks microglial phagocytosis of apoptotic cells, is a specific group III metabotropic glutamate receptor (mGluR) agonist.
|
-
International Journal of Molecular Sciences, 2022, 10551
-
Int J Mol Sci, 2022, 23(18)10551
-
Front Physiol, 2022, 13:1008073
|
|
| S6266 |
(S)-Glutamic acid
|
(S)-Glutamic acid (L-Glutamic acid) is an endogenous, non-selective glutamate receptor agonist.
|
-
Cell Biosci, 2024, 14(1):135
-
Cancer Sci, 2022, 113-6:1955-1967
-
CHEM ENG J, 2021, 10.1016/j.cej.2021.130083
|
|
| S4716 |
Evans Blue
|
Evans Blue (Direct Blue 53,C.I.23860) is a potent inhibitor of the uptake of L-glutamate into synaptic vesicles, also an AMPA/kainate receptor antagonist.
|
-
Cell Commun Signal, 2025, 23(1):420
-
Int J Nanomedicine, 2024, 19:6677-6692
-
J Biol Chem, 2022, 298(12):102699
|
|
| S2861 |
CTEP (RO4956371)
|
CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, and it shows >1000-fold selectivity over other mGlu receptors.
|
-
Sci Rep, 2025, 15(1):17364
-
Scientific Reports, 2025, 17364
-
EBioMedicine, 2017, 20:120-126
|
|
| S2690 |
ADX-47273
|
ADX47273 (BA 94673139) is a potent and specific mGlu5 positive allosteric modulator(PAM) with EC50 of 0.17 μM, showing no activity at other mGlu subtypes.
|
-
Journal of Biological Chemistry, 2014, 28460-28477
-
J Biol Chem, 2014, 289(41):28460-77
|
|
| S2795 |
VU 0357121
|
VU0357121 is a novel positive allosteric modulator (PAM) of mGlu5 with EC50 of 33 nM, is inactive or very weakly antagonizing at other mGlu receptor subtypes.
|
-
Sci Rep, 2025, 15(1):17364
-
PLoS One, 2020, e0228189
|
|
| S2809 |
MPEP
|
MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM, and this compound exhibits no appreciable activity at mGlu1b/2/3/4a/7b/8a/6 receptors.
|
-
Nature, 2025, 1-10
-
Mol Neurobiol, 2017, 54(7):5286-5299
|
|
| E0484 |
CNQX
|
CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) is an AMPA and kainate receptor antagonist with IC50 values are 0.3 μM and 1.5 μM for AMPA and kainate receptors, respectively. This compound is also an antagonist at the glycine modulatory site on the NMDA receptor complex (IC50 = 25 μM). It shows neuroprotective effects in models of ischemia and inhibits seizure-like activity in hippocampal neurons.
|
-
Advanced Science, November 21, 2025, e05663
-
Frontiers in Cellular Neuroscience, March 06, 2020, 24
|
|
| S4774 |
Xanthurenic Acid
|
Xanthurenic acid (xanthurenate, 8-Hydroxykynurenic acid, 4,8-Dihydroxyquinaldic acid), a molecule arising from tryptophan metabolism by transamination of 3-hydroxykynurenine, activates mGlu2/3 Metabotropic glutamate receptors (mGlu2 and mGlu3).
|
-
Acta Pharmacologica Sinica, 2025, Online ahead of print
-
Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01495-w
-
Cell Communication and Signaling, 2023, 141
|
|